Cannabis stocks news - daily news on stocks on CSE, TSX, TSXV, OTC, NASDAQ and NYSE from InvestorIdeas.com
Wednesday 18 November 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 497 (NASDAQ: $SAMA), (CSE: $DELC.C), (TSXV: $PCLO.V), (TSXV: $N.V)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 497 (NASDAQ: $SAMA), (CSE: $DELC.C), (TSXV: $PCLO.V), (TSXV: $N.V)
Today's
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, November 18, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen
to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/111820-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/11181SAMA-DELC-PCLO-N.asp
Hear Investor ideas cannabis potcast on iTunes
Today’s
podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online
shops, under the retail brand Alpine Cannabis.
In
today’s podcast we will be looking at a few private and public company
announcements.
Clever
Leaves International Inc., a leading multi-national operator and
licensed producer of pharmaceutical-grade cannabinoids, provided
an update on their current international footprint by announcing
successful exportation of cannabis products to 14 different countries and 5
continents as of Q4 of 2020. The products range from raw materials, including
active pharmaceutical ingredients (APIs) and semi-finished products, including
white label products.
Clever Leaves’ international network
highlights the Company’s ability maintain important partnerships with
regulatory agencies and governments as well as the ability to navigate pandemic-related
supply chain setbacks. In compliance with all cannabis regulations in the
countries served, the Company’s portfolio of products has been exported to
Australia, Brazil, Canada, Chile, the Czech Republic, Germany, Israel,
Netherlands, Perú, Poland, Spain, South Africa, the United Kingdom, and the
United States.
“Most of the international cannabis
industry functions like a pharmaceutical channel requiring significant
investments of time and focus by both a supplier such as Clever Leaves and its
commercial partners throughout the world. Success depends on navigating nascent
but strict regulatory systems, and relationships often require initial small
batch or sample shipments and validation before larger partnerships can emerge.
COVID-19 has introduced new challenges even when it comes to basic
transportation logistics. These milestones across our export network strengthen
our ability to deliver value to our business partners and to patients around
the world,” said Kyle Detwiler, CEO of Clever Leaves.
“The resilience, professionalism,
and creativity in times of setback, have been critical to the success of our
team to navigate complex regulatory frameworks and to meet customers' deadlines
during a time of unparalleled logistical restrictions. Additionally, we are
grateful to work in partnership with local regulatory agencies and logistics
service providers who share the same goal to bring high-quality medical
cannabis products to patients and are committed to the advancement of the
global cannabis market,” said Andrés Fajardo, President of Clever Leaves.
The Company was granted their EU GMP
certification for cannabis extracts in July 2020, establishing Clever Leaves’
facilities in Colombia as the first and only operation to be granted EU GMP
certification in Latin America and one of a select few in the world. The
certification, which is generally required to import medical cannabis products
into the European Union, allows Clever Leaves to produce API, semi-finished and
finished products to be distributed in pharmaceutical channels. Additionally,
in August 2020, Clever Leaves was granted a provisional license in Portugal
from Infarmed, the Portuguese health authority that allows Clever Leaves to
cultivate, import and export dry flower for medicinal and research purposes.
Clever Leaves recently announced
that it amended its definitive agreement with Schultze Special Purpose Acquisition Corp. (NASDAQ:
SAMA), pursuant to which a newly formed holding company,
Clever Leaves Holdings Inc. will acquire SAMA and Clever Leaves. The
transaction is expected to close in the fourth quarter of 2020, with Holdco
anticipated to become a Nasdaq-listed public company trading under the ticker symbol
“CLVR".
Delic
Holdings Inc., a psychedelic-focused media, e-commerce and event
company, announced that
effective at market open today, the Company will begin trading on the Canadian
Securities Exchange under the ticker symbol (CSE:
DELC).
Jackee Stang, CEO of DELIC comments
“Canada has consistently shown leadership in helping cannabis and now
psychedelics emerge from false stigmas. Canada was the first G7 country to
legalize cannabis, and as psychedelics further gain ground on what may appear
as false stigmas, the health and wellness sector will only grow. As such, the
DELIC community is deeply proud to be a part of the Canadian Securities
Exchange. We started DELIC to mainstream the psychedelic conversation, advocate
for cognitive freedom and ultimately see an end to the War on Drugs.”
Ms. Stang continued, “As the first
ever psychedelic wellness corporation, it is our mission to open the doors of
psychedelic healing to the masses. We decided to take DELIC public because we
believe that psychedelic wellness should be open to everyone... All people from
diverse backgrounds and varied life experiences. DELIC is the first ever
psychedelic wellness company designed to disrupt the status quo by diversifying
our operations, maintaining sensible messaging and intentionally avoiding
dogmatic practices or binary rhetoric. We believe in being pragmatic and
maintaining a clear-headed approach as the psychedelic sector continues to
build.”
In conjunction with the
previously-announced business combination with Molystar Resources Inc., DELIC
raised $3,475,500
through a non-brokered private placement offering.
On November 17, 2020, the Company
issued an aggregate of 3,450,000 options to directors, officers and certain
advisors pursuant to the Company’s share compensation plan — each with an
exercise price of $0.25, vesting as to 1/3 of such options on each of the 6, 12
and 18-month anniversaries, and expiring in three years.
PharmaCielo
Ltd. (TSXV:
PCLO) (OTCQX:
PCLOF), the Canadian parent of Colombia's premier cultivator
and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia
Holdings S.A.S., announced
that
it has delivered its first commercial shipment of medicinal grade CBD isolate
to a well-established, bulk distributor and white label manufacturer based in
the U.K., with sales and distribution operations in the U.K., and the E.U.
In addition, the Company has reached
an interim sales agreement with the Customer, lasting until the end of Q1-2021,
at which point PharmaCielo expects to have submitted a Novel Foods
authorization application for its range of CBD extracts. The interim, renewable
agreement enables continued shipments for the remainder of 2020 and calls for
the shipment of up to 1,000 kg of CBD Isolate and Broad-Spectrum CBD based on
the Customer's specifications, during Q1-2021. With submission of the Novel
Foods authorization application prior to March 31, the Company expects to be in
a position to subsequently expand both volume and exported consumable product
types during fiscal 2021 in accordance with regulatory requirements.
"As consumer demand for health
and wellness products containing cannabinoids continues to expand, PharmaCielo
is well-positioned to deliver a portfolio of medicinal-grade extracts at scale
to serve the needs of global CBD-market facing providers," said David
Attard, CEO of PharmaCielo Ltd. "Having focused to date on building a
world-class infrastructure in Colombia as well as developing a robust product
portfolio, we are ideally positioned to become the supplier of choice for large
volume B2B sales globally. 2021 will be a very exciting year for the Company as
we significantly expand global export volumes, and the addition of the
Customer's relationships throughout international markets long-term, including
the U.K. and E.U., support this focus."
Distribution of CBD products by the
Company under its interim sales agreement with the Customer is subject to the
approval of the TSX Venture Exchange (the "TSXV").
Namaste
Technologies Inc. (TSXV:
N)
(OTC:
NXTTF), a leading platform for cannabis products,
accessories, and education, announced that it
has entered into a share purchase agreement to acquire the remaining 49%
interest in CannMart Labs Inc., an applicant for a processing licence under the
Cannabis Act (Canada) for cannabis extraction activities.
Transaction Highlights:
● Namaste
to acquire remaining 49% of CannMart Labs to 100% ownership
● CannMart
Labs facility in Ontario is completed for BHO extraction using leading
extraction technology, making it one of only a few facilities in Canada with
such capabilities
● Application
in final phase for a processing licence from Health Canada
● Set to
produce in-house branded Cannabis 2.0 products for medical channel customers at
CannMart.com and recreational customers across Canada through sister company
CannMart Inc.'s network of provincial sales partners
● Cannabis
2.0 products initially planned include shatter and live resin with capabilities
to expand future distillate product offerings to vape cartridges, gel capsules,
tinctures and edibles
In May 2018, Namaste acquired a 51%
interest in CannMart Labs and agreed to finance the construction of its
facility in Etobicoke, Ontario, a purpose-built oil extraction facility which
incorporates a leading extraction technology facility designed to meet EU Good
Manufacturing Practice (EU-GMP) certification requirements.
"Acquiring the remaining
interest in CannMart Labs is another important milestone achieved in
establishing Namaste as a leading company within the Canadian cannabis
sector," said Meni Morim, Chief Executive Officer of Namaste.
"CannMart Labs is in the final stage of its application for an important
processing licence from Health Canada. It has installed state-of-the-art
extraction technology in its facility, which when granted a licence, will be
able to produce an array of cannabis products including shatter and live resin,
as well as future distillate products such as vape cartridges, gel capsules,
tinctures and edibles."
Mr Morim added: "This
transaction is advantageous to Namaste shareholders as the Vendors will
continue to provide management services and will receive earn-out payments in
the form of Namaste common shares or cash only upon the successful achievement
of certain revenue and gross profit targets and if the targets are met, the
cash payment option allows Namaste to minimize dilution associated with the
acquisition. We are working hard towards receiving our processing licence from
Health Canada and look forward to producing in house branded Cannabis 2.0
products, for our medical channel customers at CannMart.com and recreational
consumers across Canada through our network of provincial sales partners."
Under the terms of the proposed
transaction (the "Proposed Transaction"), Namaste will acquire the
remaining 49% interest of CannMart Labs from MKD Holdings Inc. and JLLS
Holdings Inc. in exchange for a purchase price of $4,034,000. A first tranche
of the Purchase Price of $1,608,500 will be paid to the Vendors in common
shares of Namaste issued at a deemed price equal to the seven day volume
weighted average price of Namaste's common shares on the TSX Venture Exchange
(the "VWAP") on the closing date of the Proposed Transaction. The
remaining Purchase Price of $2,425,500 is payable to the Vendors in equal
tranches over the next nine fiscal quarters beginning on the fiscal quarter
ending February 28, 2021, at the VWAP on the date of issuance required within 5
days of the end of the applicable fiscal quarter.
Once again, today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's products are
laboratory tested to ensure the end users have access to a standardized, safe
and consistent product. Cannabis Suisse Corp. currently sells via a
distribution network of Swiss retailers and online shops, under the retail
brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI),is
a paid featured company on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
Tuesday 17 November 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 496 (NASDAQ: $GNLN), (CSE: $JUVA.C) (TSX: $VLNS.TO)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 496 (NASDAQ: $GNLN), (CSE: $JUVA.C) (TSX: $VLNS.TO)
Today's
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, November 17, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen
to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/111720-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/11171GNLN-JUVA-VLNS.asp
Hear Investor ideas cannabis potcast on iTunes
Today’s
podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing residual
solvents during packaging and storage of CBD products. Cannabis Suisse Corp.
currently sells via a distribution network of Swiss retailers and online shops,
under the retail brand Alpine Cannabis.
In
today’s podcast we will be looking at a few public announcements.
Greenlane
Holdings, Inc. (NASDAQ:
GNLN), one of the largest global sellers of premium
cannabis accessories and specialty vaporization products, reported its
financial results for the third quarter ended September 30, 2020.
Third Quarter 2020 Highlights
●
Net sales of the Company's Greenlane Brands
grew approximately 65% to $5.6 million in Q3 2020 compared to $3.4 million in
Q3 2019;
●
Core revenue (defined as non-nicotine
revenue) grew 36% to $32.3 million in Q3 2020, compared to $23.8 million in Q3
2019;
●
Total revenue grew 10% to approximately
$35.8 million in Q3 2020 compared to $32.4 million in Q2 2020;
●
Excluding the impact of certain inventory
adjustments which incurred in the quarter, gross profit would have been $7.3
million or 20.4% of net sales, a 610 basis point year over year improvement in
gross profit percentage as compared to Q3 2019;
●
Expanded management team through key hires
to support Greenlane sales and marketing efforts in North America and Europe;
●
Launched a first-of-its-kind line of
responsibly sourced, precision-manufactured, pre-rolled cones made from
organically-sourced paper exclusively processed in France and sealed with 100%
natural Arabic gum;
●
Obtained the exclusive right to expand the
availability of Marley Naturals Accessories to specialty locations in Europe,
Central and South America, and the Caribbean;
“During the third quarter, with the
help of our new senior leadership team, we acted on several key initiatives
related to our go forward category emphasis, organizational structure, and
related staffing levels. Building on the success we've achieved in growing
Greenlane brands and non-nicotine sales year over year by 65% and 36%,
respectively, we've taken additional decisive steps to de-emphasize certain
product lines, invest in our fastest growing and highest margin opportunities,
and further reduced our headcount by 4.5%,” said Aaron LoCascio, Greenlane’s
Chairman and Chief Executive Officer. “While this has had an impact on our Q3
financials, we believe these decisions have positioned Greenlane to return to
near-term profitability and long term success."
Mr. LoCascio added, "We are
building a comprehensive suite of high-quality, Greenlane branded products
which will enable us to capture more of the margin on each product we sell. At
the same time, we continue to work very closely with our brand partners to
launch innovative new products into the market leveraging our best-in-class
global distribution platform. I remain very encouraged that we are on track to
enter 2021 on a solid footing, returning to positive adjusted EBITDA in the
first quarter as a result of the changes we have implemented.”
Juva
Life Inc. (CSE:
JUVA) (OTC:
JUVAF), a premier California based multi-faceted life
sciences company focused on the commercialization of Cannabis products and
formulations, announced the
commencement of trading its common shares on the Canadian Securities Exchange
(“CSE”) under the ticker symbol “JUVA.” Additional information is being updated
on the Company website at www.juvalife.com.
Juva Life Inc. USA, a California
corporation and wholly owned subsidiary of Juva Life Inc. (as of May 30, 2019)
was originally incorporated in 2018 and represents the culmination of decades
of concentrated effort in the cannabis sector. Juva Stockton Inc., a wholly
owned subsidiary of Juva Life Inc., holds a Conditional Use Permit (“CUP”) from
the city of Stockton, California which, subject to certain conditions, permits
the Company to cultivate, manufacture, distribute and deliver cannabis for the
medical and recreational markets within the State. Juva Stockton successfully
launched its delivery service from this location on the 16th of
October 2020. Additionally, in January 2020, after a 2.5-year process,
Precision Apothecary Inc, a wholly owned subsidiary of Juva Life Inc., now
holds a CUP allowing for a Microbusiness operation in the City of Hayward,
California. This permit allows Juva to cultivate, manufacture, distribute and
operate a retail cannabis storefront and delivery business in that
municipality. Concurrently, the Company’s Redwood City delivery location has
been fully operational since February 2020 and has experienced double-digit
growth month over month since commencement of operations.
Under the guidance of founder &
CEO Doug Chloupek, the Juva Life team brings together over 20 years of
extensive leadership experience in the cannabis sector. Their knowledge and
experience provide operational oversight and understanding of the California
cannabis market. The Company is comprised of six divisions: cultivation,
research, manufacturing, distribution, retail, and delivery. Each division
services specific vertical markets within a fully integrated framework under
the guiding premise of commercially engaging the many ways cannabis can
fundamentally improve individual quality of life.
Mr. Doug Chloupek, CEO and Founder
of Juva Life Inc. states, “Our journey has been truly extraordinary to-date. We
are extremely grateful to have completed an extraordinarily successful
Regulation-A+ financing along with several traditional financings. These
financings have provided us the cash on hand to execute our strategy while
concurrently moving ahead with today’s public listing and access to an even
broader investment community. We are thrilled to start our journey as a
publicly listed issuer today. We sincerely value the participation of the
investment community and have made it a key pillar and measure of our success
to strategically build shareholder value as we forge ahead in this exciting and
evolving industry sector.”
As part of the Company’s disclosure
obligations as a public issuer, ongoing financial and material filings can be
found on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com.
The
Valens Company Inc. (TSX:
VLNS) (OTCQX:
VLNCF) announced the addition
of SōRSE Clear, a stable, clear emulsion with a minimal sensory profile, to the
SōRSE by Valens offering for CBD isolate product formats.
SōRSE Technology is a water-soluble
emulsion technology designed for product developers to provide consumers with a
more consistent cannabinoid experience with user-controlled dosing,
demonstrated shelf-stability, and safe ingredients. The Valens Company has been
leveraging this emulsion technology to transform cannabis extracts into
water-soluble forms and to infuse beverages, edibles and topicals without a
cannabis aroma and after-taste.
"As the exclusive partner for
the development and custom manufacturing of best-in-class cannabis derivative
products in Canada, having access to the highest quality cannabinoid emulsion
technology is critically important," said Tyler Robson, Chief Executive
Officer of The Valens Company. "We have made great strides revolutionizing
many of our product lines with SōRSE by Valens, including more mature formats
such as tinctures, and the addition of SōRSE Clear will only deepen our ability
to innovate a diverse portfolio of products for the forthcoming 3.0
market."
SōRSE Clear is currently available
in a liquid format and contains safe, vegan, allergen-free ingredients. The new
emulsion offering features multiple benefits including stability, safety,
improved sensory experience, homogeneity, and seamless integration. SōRSE Clear
also complies with all the main safety and testing protocols, including Good
Manufacturing Practices (GMP) and The Global Safety Food Initiative (GFSI).
Howard Lee, Chief Executive Officer
of SōRSE, said, "We believe that SōRSE Clear is a game-changer for the
cannabis industry and we have no doubt that The Valens Company will harness
this technology to continue to formulate the most innovative, premium
cannabis-infused products for Canadian consumers."
Lastly, on an unrelated note to
cannabis we look at NeoPollard
Interactive LLC who was “proud
to announce its successful launch into the Canadian
market through its new agreement with the Alberta Gaming, Liquor and Cannabis
Commission ("AGLC").
Contracted as the operator of AGLC's
program, PlayAlberta.ca, NPi deployed its cutting-edge technology, a full suite
of managed services, and its top performing game content on September 30, 2020.
"PlayAlberta.ca is another way
AGLC is implementing its promise to generate revenues for the benefit of
Albertans," said Alain Maisonneuve, President and CEO of AGLC. "AGLC
is excited to work with NPi and apply their vast experience as we provide a
regulated online gambling website that will offer players expanded
entertainment options with integrated responsible gambling features and
generate revenue to support valuable programs and services Albertans rely on
every day."
What a sad day for Canada and more
specifically Alberta in this case.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI),is
a paid featured company on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)
You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...